Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03265600 · ClinicalTrials.gov registry record · NA

Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 2)

A NA study, sponsored by Cambridge Health Alliance.

Completed
Registry status
NA
Development phase
136
Enrollment target

NCT03265600: Completed NA study, sponsored by Cambridge Health Alliance.

NCT03265600 is a NA study that has completed, run by Cambridge Health Alliance. The registered enrollment target is 136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03265600, a NA study, has completed, sponsored by Cambridge Health Alliance.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target

Study Summary

Among primary care patients, compare the effectiveness of an 8-week mindfulness-based intervention (Mindfulness Training for Primary Care\[MTPC\]) vs. a low-dose mindfulness introduction comparator on self-management of chronic illness and illness-related health behavior action plan initiation, as well as on measures related to anxiety, depression, and stress.

Primary Outcome

The Action Plan Initiation Survey (APIS-5) is a 5-item self-report questionnaire adapted from a measure used by Guck et al. Participants are asked to indicate how successful they were in meeting a previously set Action Plan by using a 7-point Likert scale from 1 (Not met at all) to 7 (Totally met), with a score of 5 or above indicating successful initiation of the goal. For each unmet goal, patients are asked to further rate the cause of not meeting the goal by using a 7-point Likert rating scal

Interventions

  • BEHAVIORAL Mindfulness Training for Primary Care
  • BEHAVIORAL 60-minute Introduction to Mindfulness

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2017-02-01
Est. Completion 2020-08-01
Phase NA
Cambridge Health Alliance

45 total trials

What the finished NCT03265600 record still lists

NCT03265600 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Mindfulness Training for Primary Care is the first listed.

NCT03265600 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03265600 about?

NCT03265600 is a clinical study titled "Integrating Mindfulness Into the Patient-Centered Medical Home (Phase 2)". Among primary care patients, compare the effectiveness of an 8-week mindfulness-based intervention (Mindfulness Training for Primary Care\[MTPC\]) vs. a low-dose mindfulness introduction comparator on self-management of chronic illness and illness-related health behavior action plan initiation, as w...

What is the current status of trial NCT03265600?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2017-02-01. Estimated completion is 2020-08-01.

What interventions are being tested in trial NCT03265600?

The interventions under investigation include: Mindfulness Training for Primary Care (BEHAVIORAL), 60-minute Introduction to Mindfulness (BEHAVIORAL).

Who is sponsoring clinical trial NCT03265600?

This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03265600's enrollment target sits among peer trials

136 722nd of 2000 higher than 1,275 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03265600, the US trial registry maintained by the National Library of Medicine. NCT03265600 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.